Last updated on January 2019

A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.

Brief description of study

This study is to evaluate the safety, tolerability and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese subjects aged 6 to 64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines.

Clinical Study Identifier: NCT03571607

Contact Investigators or Research Sites near you

Start Over

Pfizer Call Center

Medical Co.LTA PS Clinic
Fukuoka, Japan

Pfizer Call Center

Fukuoka Children's Hospital
Fukuoka, Japan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.